I agree that this site is using cookies. You can find further informations here.
X
López-Tejada, Araceli
329  results:
Search for persons X
?
1

Autologous patient-derived exhausted nano T-cells exploit t..:

Blaya-Cánovas, José L. ; Griñán-Lisón, Carmen ; Blancas, Isabel...
Molecular Cancer.  23 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

Unlocking the effective alliance of β-lapachone and hydroxy..:

Calahorra, Jesús ; Blaya-Cánovas, José L. ; Castellini-Pérez, Olivia...
Biomedicine & Pharmacotherapy.  174 (2024)  - p. 116439 , 2024
Link: https://doi.org/10.1016/..
 
?
3

TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Ne..:

López-Tejada, Araceli ; Griñán-Lisón, Carmen ; González-González, Adrián...
International Journal of Biological Sciences.  19 (2023)  1 - p. 204-224 , 2023
Link: https://doi.org/10.7150/..
 
?
4

Nanomedicine as a Promising Tool to Overcome Immune Escape ..:

Navarro-Ocón, Alba ; Blaya-Cánovas, Jose L. ; López-Tejada, Araceli...
Pharmaceutics.  14 (2022)  3 - p. 505 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Antioxidants for the Treatment of Breast Cancer: Are We The..:

Griñan-Lison, Carmen ; Blaya-Cánovas, Jose L. ; López-Tejada, Araceli...
Antioxidants.  10 (2021)  2 - p. 205 , 2021
Link: https://doi.org/10.3390/..
 
?
6

Drug Repurposing for Triple-Negative Breast Cancer:

Ávalos-Moreno, Marta ; López-Tejada, Araceli ; Blaya-Cánovas, Jose L....
Journal of Personalized Medicine.  10 (2020)  4 - p. 200 , 2020
Link: https://doi.org/10.3390/..
 
?
7

TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Ne..:

López-Tejada, Araceli ; Griñán-Lisón, Carmen ; González-González, Adrián...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760438/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

Nanomedicine as a Promising Tool to Overcome Immune Escape ..:

Navarro-Ocón, Alba ; Blaya-Cánovas, Jose L ; López-Tejada, Araceli...
1999-4923.  , 2022
Link: http://hdl.handle.net/10..
 
?
9

Antioxidants for the Treatment of Breast Cancer: Are We The..:

Griñan-Lison, Carmen ; Blaya-Cánovas, Jose L ; López-Tejada, Araceli...
2076-3921.  , 2021
Link: http://hdl.handle.net/10..
 
?
10

Antioxidants for the Treatment of Breast Cancer: Are We The..:

Griñan-Lison, Carmen ; Blaya-Cánovas, Jose L ; López-Tejada, Araceli...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911462/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Antioxidants for the Treatment of Breast Cancer: Are We The..:

Griñan-Lison, Carmen ; Blaya-Cánovas, Jose L ; López-Tejada, Araceli...
https://www.mdpi.com/2076-3921/10/2/205/htm.  , 2021
Link: http://hdl.handle.net/10..
 
?
12

Drug Repurposing for Triple-Negative Breast Cancer:

Ávalos-Moreno, Marta ; López-Tejada, Araceli ; Blaya-Cánovas, Jose L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711505/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
13

Drug Repurposing for Triple-Negative Breast Cancer:

Ávalos-Moreno, Marta ; López-Tejada, Araceli ; Blaya-Cánovas, Jose L...
https://www.mdpi.com/2075-4426/10/4/200/htm.  , 2020
Link: http://hdl.handle.net/10..
 
?
14

Nanomedicine as a Promising Tool to Overcome Immune Escape ..:

Alba Navarro-Ocón ; Jose L. Blaya-Cánovas ; Araceli López-Tejada...
Nanomedicine and Nanotechnology.  , 2022
Link: https://doi.org/10.3390/..
 
?
15

Nanomedicine as a Promising Tool to Overcome Immune Escape ..:

Alba Navarro-Ocón ; Jose L. Blaya-Cánovas ; Araceli López-Tejada...
https://www.mdpi.com/1999-4923/14/3/505.  , 2022
Link: https://doi.org/10.3390/..
 
1-15